000 01441 a2200397 4500
005 20250515145226.0
264 0 _c20090611
008 200906s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2008.317
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaras-Kuzelicki, N
245 0 0 _aHeterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients.
_h[electronic resource]
260 _bLeukemia
_cMay 2009
300 _a971-4 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aFemale
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHeterozygote
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMercaptopurine
_xpharmacology
650 0 4 _aMethylenetetrahydrofolate Reductase (NADPH2)
_xgenetics
650 0 4 _aMethyltransferases
_xgenetics
650 0 4 _aMutation
_xgenetics
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xenzymology
650 0 4 _aRetrospective Studies
700 1 _aJazbec, J
700 1 _aMilek, M
700 1 _aMlinaric-Rascan, I
773 0 _tLeukemia
_gvol. 23
_gno. 5
_gp. 971-4
856 4 0 _uhttps://doi.org/10.1038/leu.2008.317
_zAvailable from publisher's website
999 _c18448804
_d18448804